Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease

References

• Gupta A, Dawson VL, Dawson TM. What causes cell death in Parkinson’s disease? Ann Neurol 2008;64(Suppl 2):3–15.
   Google Scholar
• Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008;4:600–609.
   PubMedGoogle Scholar
• Bové J, Prou D, Perier C, Przedborski S. Toxin-induced models of Parkinson’s disease. Neuro Rx. 2005;2:484–;494.
   Google Scholar
• Langston JW, Langston EB, Irwin I. MPTP-induced parkinsonism in human and non-human primates—clinical and experimental aspects. Acta Neurol Scand Suppl 1984;100:49–54.
   PubMedGoogle Scholar
• Salach JI, Singer TP, Castagnoli N, Jr, Trevor A. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP. Biochem Biophys Res Commun. 1984;125:831–835.
   PubMed Web of Science ®Google Scholar
• Javitch JA, D’Amato RJ, Strittmatter SM, Snyder SH. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 1985;82:2173–2177.
   PubMed Web of Science ®Google Scholar
• Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl- pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 1985;36:2503–2508.
   PubMed Web of Science ®Google Scholar
• Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson’s disease. Lancet 1989;1:1269.
   PubMed Web of Science ®Google Scholar
• Schapira AH. Evidence for mitochondrial dysfunction in Parkinson’s disease—a critical appraisal. Mov Disord 1994;9: 125–138.
   PubMed Web of Science ®Google Scholar
• Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease. J Neurochem 1990;55:2142–2145.
   PubMed Web of Science ®Google Scholar
• Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AH. Platelet mitochondrial function in Parkinson’s disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann Neurol. 1992 Dec; 32(6):782–788.
   Google Scholar
• Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R, Shults CW. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson’s disease. Ann Neurol 1995;37:714–722.
   PubMed Web of Science ®Google Scholar
• Ikebe S, Tanaka M, Ohno K, Sato W, Hattori K, Kondo T, Mizuno Y, Ozawa T. Increase of deleted mitochondrial DNA in the striatum in Parkinson’s disease and senescence. Biochem Biophys Res Commun 1990;170:1044–1048.
   Web of Science ®Google Scholar
• Keeney PM, Xie J, Capaldi RA, Bennett JP, Jr. Parkinson’s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 2006;26:5256–5264.
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP, Jr, Davis RE, Parker WD, Jr. Origin and functional consequences of the complex I defect in Parkinson’s disease. Ann Neurol 1996;40:663–671.
   PubMed Web of Science ®Google Scholar
• Gu M, Cooper JM, Taanman JW, Schapira AH. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson’s disease. Ann Neurol 1998;44:177–186.
   PubMed Web of Science ®Google Scholar
• Przedborski S, Tieu K, Perier C, Vila M. MPTP as a mitochondrial neurotoxic model of Parkinson’s disease. J Bioenerg Biomembr 2004;36:375–379.
   PubMed Web of Science ®Google Scholar
• Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 2000;3:1301–1306.
   PubMed Web of Science ®Google Scholar
• Carroll J, Fearnley IM, Shannon RJ, Hirst J, Walker JE. Analysis of the subunit composition of complex I from bovine heart mitochondria. Mol Cell Proteomics 2003;2:117–126.
   PubMed Web of Science ®Google Scholar
• Carroll J, Shannon RJ, Fearnley IM, Walker JE, Hirst J. Definition of the nuclear encoded protein composition of bovine heart mitochondrial complex I. Identification of two new subunits. J Biol Chem 2002;277:50311–50317.
   Google Scholar
• Berrisford JM, Sazanov LA. Structural basis for the mechanism of respiratory complex I. J Biol Chem 2009;284:29773–29783.
   PubMed Web of Science ®Google Scholar
• Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 2002;80:780–787.
   PubMed Web of Science ®Google Scholar
• Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD. Oxidative stress as a cause of nigral cell death in Parkinson’s disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson’s Disease Research Group. Ann Neurol 1992;32(Suppl):S82–S87.
   Google Scholar
• Perry TL, Godin DV, Hansen S. Parkinson’s disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 1982;33:305–310.
   PubMed Web of Science ®Google Scholar
• Perry TL, Yong VW. Idiopathic Parkinson’s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 1986;67:269–274.
   PubMed Web of Science ®Google Scholar
• Pearce RK, Owen A, Daniel S, Jenner P, Marsden CD. Alterations in the distribution of glutathione in the substantia nigra in Parkinson’s disease. J Neural Transm 1997;104:661–677.
   PubMed Web of Science ®Google Scholar
• Jenner P. Presymptomatic detection of Parkinson’s disease. J Neural Transm 1993;40(Suppl):23–36.
   Google Scholar
• Jha N, Jurma O, Lalli G, Liu Y, Pettus EH, Greenamyre JT, Liu RM, Forman HJ, Andersen JK. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson’s disease. J Biol Chem 2000;275:26096–26101.
   PubMed Web of Science ®Google Scholar
• Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, Murphy MP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 2003;278:19603–19610.
   PubMed Web of Science ®Google Scholar
• Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, Murphy MP. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J Biol Chem 2004;279:47939–47951.
   PubMed Web of Science ®Google Scholar
• Lee DW, Kaur D, Chinta SJ, Rajagopalan S, Andersen JK. A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson’s disease. Antioxid Redox Signal 2009;11:2083–2094.
   Google Scholar
• Hsu M, Srinivas B, Kumar J, Subramanian R, Andersen J. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson’s disease. J Neurochem 2005;92:1091–1103.
   PubMed Web of Science ®Google Scholar
• Chinta SJ, Andersen JK. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson’s disease. Free Radic Biol Med 2006;41:1442–1448.
   Google Scholar
• Boveris A, Costa LE, Cadenas E, Poderoso JJ. Regulation of mitochondrial respiration by adenosine diphosphate, oxygen and nitric oxide. Methods Enzymol 1999;301:188–198.
   PubMed Web of Science ®Google Scholar
• Clementi E, Brown GC, Feelish M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 1998;95:7631–7636.
   PubMed Web of Science ®Google Scholar
• Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Proc Natl Acad Sci USA 1990;87:1620–1624.
   Google Scholar
• Poderoso JJ, Carreras MC, Schöpfer F, Lisdero CL, Riobó NA, Giulivi C, Boveris AD, Boveris A, Cadenas E. The reaction of nitric oxide with ubiquinol: kinetic properties and biological significance. Free Radical Biol Med 1999;26:925–;935.
   PubMed Web of Science ®Google Scholar
• Poderoso JJ, Lisdero C, Schöpfer F, Riobó N, Carreras MC, Cadenas E, Boveris A. The regulation of mitochondrial oxygen uptake by redox reactions involving nitric oxide and ubiquinol. J Biol Chem 1999;274:37709–;37716.
   PubMed Web of Science ®Google Scholar
• Borutaite V, Brown GC. S-nitrosothiol inhibition of mitochondrial complex I causes a reversible increase in mitochondrial hydrogen peroxide production. Biochim Biophys Acta 2006;1757:562–566.
   Google Scholar
• Ramachandran A, Ceaser E, Darley-Usmar VM. Chronic exposure to nitric oxide alters the free iron pool in endothelial cells: role of mitochondrial respiratory complexes and heat shock proteins. Proc Natl Acad Sci USA 2004;101:384–389.
   PubMed Web of Science ®Google Scholar
• Dahm CC, Moore K, Murphy MP. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J Biol Chem 2006:281:10056–10065.
   Google Scholar
• Bolanos JP, Almeida A, Stewart V, Peuchan S, Land JM, Clark JB, Heales SJR. J Neurochem 1997;68:2227–2240.
   PubMed Web of Science ®Google Scholar
• Burwell LS, Nadtochiy SM, Tompkins AJ, Young S, Brookes PS. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J 2006;394:627–634.
   PubMed Web of Science ®Google Scholar
• Chinta SJ, Kumar MJ, Hsu M, Rajagopalan S, Kaur D, Rane A, Nicholls DG, Choi J, Andersen JK. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J Neurosci 2007; 27:13997–14006.
   PubMed Web of Science ®Google Scholar
• Galkin A, Moncada S. S-nitrosation of mitochondrial complex I depends on its structural conformation. J Biol Chem 2007;282:37448–37453.
   PubMed Web of Science ®Google Scholar
• Antunes F, Nunes C, Laranjinha J, Cadenas E. Redox interactions of nitric oxide with dopamine and its derivatives. Toxicology 2005;208:207–212.
   PubMed Web of Science ®Google Scholar
• Boveris A, Cadenas E. Cellular sources and steady-state levels of reactive oxygen species. Clerch LB, Massaro DJ. Oxygen, gene expression, and cellular function. New York: Marcel Dekker; 1997. 1–25.
   Google Scholar
• Alvarez B, Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 2003;25:295–311.
   PubMed Web of Science ®Google Scholar
• Pennathur S, Jackson-Lewis V, Przedborski S, Heinecke JW. Mass spectrometric quantification of 3-nitrotyrosine, orthotyrosine, and o, o-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson’s disease. J Biol Chem 1999;274:34621–34628.
   PubMed Web of Science ®Google Scholar
• Ferrante RJ, Hantraye P, Brouillet E, Beal MF. Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase. Brain Res 1999;823:177–182.
   PubMed Web of Science ®Google Scholar
• Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000;290:985–989.
   PubMed Web of Science ®Google Scholar
• Riobó NA, Clementi E, Melani M, Boveris A, Cadenas E, Moncada S, Poderoso JJ. Nitric oxide inhibits mitochondrial NADH: ubiquinone reductase activity through peroxynitrite formation. Biochem J 2001;359:139–;145.
   PubMed Web of Science ®Google Scholar
• Murray J, Taylor SW, Zhang B, Ghosh SS, Capaldi RA. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem 2003;278:37223–37230.
   PubMed Web of Science ®Google Scholar
• Murray J, Zhang B, Taylor SW, Oglesbee D, Fahy E, Marusich MF, Ghosh SS, Capaldi RA. Analysis of the subunit composition of complex I from bovine heart mitochondria. J Biol Chem 2003;278:13619–13622.
   PubMed Web of Science ®Google Scholar
• Carroll J, Shannon RJ, Fearnley IM, Walker JE, Hirst J. Definition of the nuclear encoded protein composition of bovine heart mitochondrial complex I. Identification of two new subunits. J Biol Chem 2002;277:50311–50317.
   Google Scholar
• Carroll J, Fearnley IM, Shannon RJ, Hirst J, Walker JE. Analysis of the subunit composition of complex I from bovine heart mitochondria. Mol Cell Proteomics 2003;2:117–126.
   PubMed Web of Science ®Google Scholar
• Bharath S, Andersen JK. Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson’s disease. Antioxid Redox Signal 2005;7:900–910.
   PubMed Web of Science ®Google Scholar
• Choi DY, Liu M, Hunter RL, Cass WA, Pandya JD, Sullivan PG, Shin EJ, Kim HC, Gash DM, Bing G. Striatal neuroinflammation promotes Parkinsonism in rats. PLoS One 2009; 4:e5482.
   Google Scholar
• Davis CW, Hawkins BJ, Ramasamy S, Irrinki KM, Cameron BA, Islam K, Daswani VP, Doonan PJ, Manevich Y, Madesh M. Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis. Free Radic Biol Med 2010;48:306–317.
   PubMedGoogle Scholar